Asperger syndrome future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
== Overview == | == Overview == | ||
There have been some experimental therapy and suggestions such as oxytosin and treatment with stem cells in patients with Asperger Syndrome (AS). | There have been some experimental therapy and suggestions such as oxytosin and treatment with stem cells in patients with Asperger Syndrome (AS).<ref name="pmid25655905">{{cite journal| author=Tarazi FI, Sahli ZT, Pleskow J, Mousa SA| title=Asperger's syndrome: diagnosis, comorbidity and therapy. | journal=Expert Rev Neurother | year= 2015 | volume= 15 | issue= 3 | pages= 281-93 | pmid=25655905 | doi=10.1586/14737175.2015.1009898 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25655905 }} </ref> | ||
== Future or Investigational Therapies == | == Future or Investigational Therapies == | ||
Experimental therapy for Asperger Syndrome (AS) include: | Experimental therapy for Asperger Syndrome (AS) include:<ref name="pmid25655905">{{cite journal| author=Tarazi FI, Sahli ZT, Pleskow J, Mousa SA| title=Asperger's syndrome: diagnosis, comorbidity and therapy. | journal=Expert Rev Neurother | year= 2015 | volume= 15 | issue= 3 | pages= 281-93 | pmid=25655905 | doi=10.1586/14737175.2015.1009898 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25655905 }} </ref> | ||
=== Oxytocin === | === Oxytocin === | ||
* Contributions to repetitive behaviors and social deficiencies in Asperger Syndrome (AS) by oxytosin have suggested oxytocin as an experimental therapy in autism spectrum disorder (ASD) and Asperger Syndrome (AS).<ref name="pmid12496956">{{cite journal| author=Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR | display-authors=etal| title=Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. | journal=Neuropsychopharmacology | year= 2003 | volume= 28 | issue= 1 | pages= 193-8 | pmid=12496956 | doi=10.1038/sj.npp.1300021 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12496956 }} </ref> | |||
* Contributions to repetitive behaviors and social deficiencies in Asperger Syndrome (AS) by oxytosin have suggested oxytocin as an experimental therapy in autism spectrum disorder (ASD) and Asperger Syndrome (AS). | * In patients with AS and ASD, the preliminary manipulation of systemic oxytocin levels have suggested a positive correlation in social awareness, social recognition and peer affiliation.<ref name="pmid20160081">{{cite journal| author=Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A| title=Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. | journal=Proc Natl Acad Sci U S A | year= 2010 | volume= 107 | issue= 9 | pages= 4389-94 | pmid=20160081 | doi=10.1073/pnas.0910249107 | pmc=2840168 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20160081 }} </ref> | ||
* In patients with AS and ASD, the preliminary manipulation of systemic oxytocin levels have suggested a positive correlation in social awareness, social recognition and peer affiliation. | |||
=== Stem cells === | === Stem cells === | ||
* Treatment of AS and ASD with stem cells is in the early stages. Trazi<br /> | * Treatment of AS and ASD with stem cells is in the early stages. Trazi<br /> | ||
==References== | ==References== | ||
Revision as of 12:44, 19 June 2020
|
Asperger Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Asperger syndrome future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Asperger syndrome future or investigational therapies |
|
FDA on Asperger syndrome future or investigational therapies |
|
CDC on Asperger syndrome future or investigational therapies |
|
Asperger syndrome future or investigational therapies in the news |
|
Blogs on Asperger syndrome future or investigational therapies |
|
Risk calculators and risk factors for Asperger syndrome future or investigational therapies |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
There have been some experimental therapy and suggestions such as oxytosin and treatment with stem cells in patients with Asperger Syndrome (AS).[1]
Future or Investigational Therapies
Experimental therapy for Asperger Syndrome (AS) include:[1]
Oxytocin
- Contributions to repetitive behaviors and social deficiencies in Asperger Syndrome (AS) by oxytosin have suggested oxytocin as an experimental therapy in autism spectrum disorder (ASD) and Asperger Syndrome (AS).[2]
- In patients with AS and ASD, the preliminary manipulation of systemic oxytocin levels have suggested a positive correlation in social awareness, social recognition and peer affiliation.[3]
Stem cells
- Treatment of AS and ASD with stem cells is in the early stages. Trazi
References
- ↑ 1.0 1.1 Tarazi FI, Sahli ZT, Pleskow J, Mousa SA (2015). "Asperger's syndrome: diagnosis, comorbidity and therapy". Expert Rev Neurother. 15 (3): 281–93. doi:10.1586/14737175.2015.1009898. PMID 25655905.
- ↑ Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR; et al. (2003). "Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders". Neuropsychopharmacology. 28 (1): 193–8. doi:10.1038/sj.npp.1300021. PMID 12496956.
- ↑ Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A (2010). "Promoting social behavior with oxytocin in high-functioning autism spectrum disorders". Proc Natl Acad Sci U S A. 107 (9): 4389–94. doi:10.1073/pnas.0910249107. PMC 2840168. PMID 20160081.